STSS · NASDAQ · Medical - Instruments & Supplies

Sharps Technology (STSS)

Markets syringe products while running a SOL-focused digital asset treasury.

$1.27
At close−0.03 (−2.31%)
No recent trading data

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000002
Cost of revenue000000011−200
Gross profit0000000−1−1200
23222212109−101525
Research & development010000000000
22222212111−9585
General & administrative00000002111−9580
Other expenses00000000−1−5−320
Operating income−2−3−2−2−2−2−1−3−111102−5−23
00100−2475−273−820
Interest income000000000000
Interest expense000000100000
Other non-operating income00−10020−7−5257820
Income before tax−2−3−1−2−2−534−105−170−86−23
Income tax expense000000000000
Net income from continuing operations−2−3−1−2−2−534−105−170−86−23
Discontinued operations000000−100000
Other adjustments000000000−1200
Net income−2−3−1−2−2−524−105−183−86−23
EPS, basic−$1,130.05−$1,340.20−$347.56−$643.63−$379.57−$662.99$38.62$3.58−$4.33−$6.26−$1.19−$0.32
EPS, diluted−$1,130.05−$1,340.20−$347.56−$643.63−$379.57−$662.99$38.62$3.58−$4.33−$6.26−$1.19−$0.32
Weighted average shares, basic0000000124257372
Weighted average shares, diluted0000000124257372
EBITDA−2−3−1−2−1−4−14−105−154−86−23
Depreciation & amortization000000000000
EBIT−2−3−1−2−2−5−14−105−154−860